AEHAU Aesther Healthcare Acquisition Corporation

On September 17, 2021, Aesther Healthcare Acquisition Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 10,500,000 units (“Units”), which included the exercise of a portion (500,000 Units) of the underwriters’ option to purchase up to an additional 1,500,000 Units to cover over-allotments. Each Unit consists of one share of Class A common stock, $0.0001 par value per share (“Common Stock”) and one half of one redeemable warrant (“Public Warrant”), with each whole Public Warrant exercisable into one share of Common Stock at an exercise price of $11.50 per share, subject to adjustment, pursuant to the Company’s registration statement on Form S-1 (File No. 333-258012). The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $105,000,000.

As previously reported on a Current Report on Form 8-K of the Company, on September 17, 2021, simultaneously with the consummation of the IPO, the Company completed the private placement (“Private Placement”) of an aggregate of 5,411,000 warrants to purchase shares of Common Stock at a purchase price of $1.00 per warrant (“Placement Warrants”), all of which were purchased by Aesther Healthcare Sponsor, LLC, generating total proceeds of $5,411,000.

A total of $107,100,000, comprised of the proceeds from the IPO and the proceeds of the Private Placement, net of the underwriting commissions, discounts, and offering expenses, was deposited in a trust account established for the benefit of the Company’s public stockholders. An audited balance sheet as of September 17, 2021 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement has been issued by the Company and is attached hereto as Exhibit 99.1.